These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2000608)

  • 1. [Results of 6 1/2 years of heart transplantation at Rikshospitalet].
    Simonsen S; Geiran O; Lindberg H; Foerster A; Hysing E; Mohr B; Forfang K; Ihlen H; Frøysaker T
    Tidsskr Nor Laegeforen; 1991 Jan; 111(3):302-5. PubMed ID: 2000608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart transplantation in patients over 54 years of age with triple-drug therapy immunosuppression.
    Fabbri A; Sharples LD; Mullins P; Caine N; Large S; Wallwork J
    J Heart Lung Transplant; 1992; 11(5):929-32. PubMed ID: 1420241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart transplantation--a two-year experience.
    Hetzer R; Warnecke H; Schüler S; Süthoff U; Borst HG
    Z Kardiol; 1985; 74 Suppl 6():51-8. PubMed ID: 3913180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of combined heart-lung transplantation: the Stanford experience.
    Sarris GE; Smith JA; Shumway NE; Stinson EB; Oyer PE; Robbins RC; Billingham ME; Theodore J; Moore KA; Reitz BA
    J Heart Lung Transplant; 1994; 13(6):940-9. PubMed ID: 7865527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart transplantation in Norway. Morphological monitoring of cardiac allograft rejection. A 3-year follow-up.
    Foerster A; Simonsen S; Frøysaker T
    APMIS; 1988 Jan; 96(1):14-24. PubMed ID: 3278719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression in live-related donor renal transplantation.
    Iman A; Rao M; Juneja R; Jacob CK
    Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with long-term survival following cardiac transplantation.
    Sareyyüpoğlu B; Kirali K; Göksedef D; Rabuş MB; Tuncer A; Erentuğ V; Mansuroğlu D; Yakut C
    Anadolu Kardiyol Derg; 2008 Oct; 8(5):360-6. PubMed ID: 18849228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of gender on heart transplantation outcomes: a single center experience.
    De Santo LS; Marra C; De Feo M; Amarelli C; Romano G; Cotrufo M
    Ital Heart J; 2002 Jul; 3(7):419-23. PubMed ID: 12189971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple-drug immunosuppression for heart transplantation in infants and children.
    Brown JW; Turrentine MW; Kesler KA; Mahomed Y; Darragh R; Evans K; Thompson L; Caldwell R
    J Heart Lung Transplant; 1993; 12(6 Pt 2):S265-74. PubMed ID: 8312346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural history of renal function following orthotopic heart transplant.
    Al Aly Z; Abbas S; Moore E; Diallo O; Hauptman PJ; Bastani B
    Clin Transplant; 2005 Oct; 19(5):683-9. PubMed ID: 16146562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
    Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
    J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience and early results following heart transplantation at the Humana Heart Institute.
    Girardet RE; Lansing AM
    J Heart Transplant; 1985; 4(5):530-4. PubMed ID: 3916530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The state of heart transplantation in Hungary].
    Bodor E; Petrohai A
    Magy Seb; 2001 Dec; 54 Suppl():31-4. PubMed ID: 11816144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Orthotopic heart transplantation at the 2d Surgical Department of the University of Vienna: 4-year experience].
    Laufer G; Havel M; Holzinger C; Wollenek G; Laczkovics A; Wolner E
    Wien Klin Wochenschr; 1989 Jan; 101(2):53-7. PubMed ID: 2644739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with cardiac retransplantation.
    Michler RE; McLaughlin MJ; Chen JM; Geimen R; Schenkel F; Smith CR; Barr ML; Rose EA
    J Thorac Cardiovasc Surg; 1993 Oct; 106(4):622-9; discussion 629-31. PubMed ID: 8412255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of infectious complications following heart transplantation with triple-drug immunotherapy.
    Andreone PA; Olivari MT; Elick B; Arentzen CE; Sibley RK; Bolman RM; Simmons RL; Ring WS
    J Heart Transplant; 1986; 5(1):13-9. PubMed ID: 3302153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation.
    Langrehr JM; Glanemann M; Guckelberger O; Klupp J; Neumann U; Machens C; Lohmann R; Knoop M; Lobeck H; Schlag H; Keck H; Settmacher U; Bechstein WO; Neuhaus PJ
    Clin Transplant; 1998 Aug; 12(4):303-12. PubMed ID: 9686324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.